Board Meeting28 Apr 2026, 04:51 pm
JPL Board to meet on May 5, 2026, for FY26 results & dividend
AI Summary
Jenburkt Pharmaceuticals Ltd has announced that its Board of Directors will convene a meeting on Tuesday, May 5, 2026. The primary agenda items for this meeting include taking on record the audited financial results for the quarter and the full financial year ended March 31, 2026. Additionally, the Board will consider and potentially recommend a dividend for the financial year, if any.
Key Highlights
- Board meeting scheduled for May 5, 2026.
- To approve audited financial results for Q4 and FY26.
- To consider recommendation of dividend, if any.
Price Impact
More from JENBURPH*
More in Board Meeting